These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Bamifylline in the treatment of chronic bronchial obstruction: a controlled clinico-functional study versus an anhydrous theophylline administered once a day]. Caputi M; Cautiero V; Aliberti M; Monici Preti PA; Oliani C Arch Monaldi Mal Torace; 1988; 43(5):409-21. PubMed ID: 3079283 [No Abstract] [Full Text] [Related]
4. [Comparison of two long-acting theophylline preparations in daily evening administration]. Holzer R Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685 [TBL] [Abstract][Full Text] [Related]
5. [Prescription of Theostat 300 as a single evening dose]. Germouty J; Bida C; Moreau L Rev Pneumol Clin; 1987; 43(5):262-5. PubMed ID: 3324266 [TBL] [Abstract][Full Text] [Related]
6. [Use of Unilair in general practice conditions. Treatment of chronic obstructive airway diseases with theophylline]. Gregori P; Hader S; Samiri H; Wiemann M; Yousif MJ; Kiebart M Fortschr Med; 1997 Jan; 115(1-2):54-5. PubMed ID: 9102383 [No Abstract] [Full Text] [Related]
8. [Clinical functional study of a new delayed-action preparation of "once a day" anhydrous theophylline in patients with chronic obstructive bronchopneumopathy]. Gatto PG; Bruzzoni A; Valenti V Clin Ter; 1989 Jul; 130(1):45-9. PubMed ID: 2529079 [TBL] [Abstract][Full Text] [Related]
9. Once-daily dosing of a new ultrasustained-release theophylline preparation. Van den Brande P; Nys J; Tjandramaga TB; Verhelst F; Demedts M Respiration; 1987; 52(2):144-53. PubMed ID: 3671893 [TBL] [Abstract][Full Text] [Related]
10. The effect of dosing time on the pharmacokinetics and pharmacodynamics of a 'once-a-day' sustained release theophylline preparation. Lamont H; Pauwels R; Van der Straeten M Br J Clin Pharmacol; 1987 Dec; 24(6):735-42. PubMed ID: 3440095 [TBL] [Abstract][Full Text] [Related]
11. [Dose titration with Euphylong following prior determination of serum concentration in the steady state]. Schnabel D; von Treufels S; Oellerich M; Böttger HC; Sybrecht GW Pneumologie; 1990 Feb; 44 Suppl 1():287-8. PubMed ID: 2367392 [TBL] [Abstract][Full Text] [Related]
12. Theophylline: taking it to a new level. Messerschmidt K S D J Med; 1996 Jun; 49(6):201-2. PubMed ID: 8693341 [No Abstract] [Full Text] [Related]
13. Influenza vaccine may enhance theophylline toxicity. A case report and review of the literature. Hamdy RC; Micklewright M; Beecham VF; Moore SW J Tenn Med Assoc; 1995 Dec; 88(12):463-4. PubMed ID: 8531477 [No Abstract] [Full Text] [Related]
14. [Tolerance of a new oral long-acting theophylline in patients with obstructive airway diseases]. Nolte D; Dusik B Fortschr Med; 1983 Jul; 101(25):1203-6. PubMed ID: 6884955 [TBL] [Abstract][Full Text] [Related]
15. Prescribing habits for theophylline preparations. Wiffen JK; Jackson SH J R Soc Med; 1983 Nov; 76(11):917-9. PubMed ID: 6631871 [TBL] [Abstract][Full Text] [Related]
16. [Results of a serum concentration-oriented dosage of a theophylline depot preparation in ambulatory patients with chronic obstructive lung disease]. Harder S; Staib AH; Stauder J Prax Klin Pneumol; 1985 Jun; 39(6):193-6. PubMed ID: 4022931 [No Abstract] [Full Text] [Related]